Literature DB >> 29629663

The Effect of Combination Antiretroviral Therapy Use Among HIV Positive Children on the Hazard of AIDS Using Calendar Year as an Instrumental Variable.

Andrew Anglemyer1, Amy Sturt2, Yvonne Maldonado2.   

Abstract

BACKGROUND: Instrumental variable (IV) analyses are a common causal inference technique used in the absence of randomized data. Combination Antiretroviral Therapy (cART) was first introduced in 1996 and calendar periods have been used as a proxy for cART use. However, cART use misclassification can bias IV analyses.
OBJECTIVE: We aim to highlight the differences in the effects of antiretroviral therapy on clinical outcomes between the applications of traditional and adapted IV analysis techniques.
METHODS: This study includes children with perinatal human immunodeficiency virus (HIV-1) infection followed from 1988 to 2009. We describe an application of traditional and adapted IV analysis techniques. Noncompliance adjustments were applied to correct the misclassification of cART-use. Weighting the inverse probability of calendar era, the selected covariates were performed to control for variables that may be related to both the IV and outcome.
RESULTS: During 48,380 person-days, 78 HIV-positive children progressed to an initial stage-3- defining diagnosis or death. The Intention to Treat (ITT) rate ratio (RR) of stage-3-defining diagnosis or death comparing the pre-cART and cART eras was estimated at 2·67 (95% confidence interval (CI): 1·.47, 4·84). The IV estimator was used to adjust for cART use misclassification, yielding an IV RR of 5·42 (95% CI: 2·99, 9·83). Weighting analyses did not markedly alter the results.
CONCLUSION: cART use decreased progression to stage-3-defining diagnosis or death. The use of noncompliance adjustments for cART misclassification in IV analyses may provide more robust evidence of cART's effectiveness than traditional ITT analysis. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  HIV infection; antiretroviral drugs; instrumental variables analysis; intention to treat analysis; mortality; pediatrics.

Mesh:

Substances:

Year:  2018        PMID: 29629663     DOI: 10.2174/1570162X16666180409150826

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  2 in total

1.  GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection.

Authors:  Shin-Ichiro Hattori; Nobuyo Higshi-Kuwata; Jakka Raghavaiah; Debananda Das; Haydar Bulut; David A Davis; Yuki Takamatsu; Kouki Matsuda; Nobutoki Takamune; Naoki Kishimoto; Tadashi Okamura; Shogo Misumi; Robert Yarchoan; Kenji Maeda; Arun K Ghosh; Hiroaki Mitsuya
Journal:  mBio       Date:  2020-08-20       Impact factor: 7.867

Review 2.  Adolescents and young adults with early acquired HIV infection in the united states: unique challenges in treatment and secondary prevention.

Authors:  Hasiya Yusuf; Allison Agwu
Journal:  Expert Rev Anti Infect Ther       Date:  2020-11-01       Impact factor: 5.091

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.